Sub Heading

Clinical Trials Details

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (DeLLphi-306)

IRB Protocol Number
20230016

Clinical Trial Categories

  • Lung Cancer
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: 

Men or women, ages 18 and older, with limited stage small cell lung cancer who have completed chemotherapy.

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.